The PolyPeptide Group works within all major peptide technologies and handles peptide production from small-scale non-good manufacturing practice (GMP) batches to multi-10kg and larger GMP manufacturing needs.

The Group has more than 50 years experience worldwide within the field of peptide development and manufacturing project.

In PolyPeptides’ facility in Malmö, Sweden, large-scale GMP manufacturing for both solid phase peptide synthesis (SPPS) and liquid phase peptide synthesis (LPPS) projects takes place.

The facility has successfully undergone approval inspections by the US Food and Drug Administration (FDA).